Telos Corporation Secures Multi-Million Dollar Contract Renewal with U.S. Air Force
ASHBURN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world's most security-conscious organizations, today announced a contract extension with the U.S. Air Force to help meet complex compliance requirements with Telos' flagship cyber governance, risk and compliance (GRC) platform, Xacta®.
The Company secured a $3.7 million option year contract with the Air Force Intelligence Community, enabling the organization to automate a significant portion of its cyber GRC requirements across multiple environments – including top secret and secret networks – by implementing Xacta.
'We're honored to continue serving the hardworking airmen of the Air Force Intelligence Community,' said John B. Wood, chairman and CEO of Telos. 'They are up against the DoD-wide challenge of meeting complex cybersecurity standards and requirements, and we're pleased to ease the compliance burden through the automation and efficiency of Xacta.'
For more information about Xacta, please visit www.telos.com/xacta.
Forward-Looking StatementsThis press release contains forward-looking statements which are made under the safe harbor provisions of the federal securities laws. These statements are based on the Company's management's current beliefs, expectations and assumptions about future events, conditions and results and on information currently available to them. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. The Company believes that these risks and uncertainties include, but are not limited to, those described under the captions 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' set forth from time to time in the Company's filings and reports with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the year ended December 31, 2024, as well as subsequent and future filings and reports by the Company, copies of which are available at https://investors.telos.com and on the SEC's website at www.sec.gov.
Although the Company bases these forward-looking statements on assumptions that the Company's management believes are reasonable when made, they caution the reader that forward-looking statements are not guarantees of future performance and that the Company's actual results of operations, financial condition and liquidity, and industry developments, may differ materially from statements made in or suggested by the forward-looking statements contained in this release. Given these risks, uncertainties and other factors, many of which are beyond its control, the Company cautions the reader not to place undue reliance on these forward-looking statements. Any forward-looking statement speaks only as of the date of such statement and, except as required by law, the Company undertakes no obligation to update any forward-looking statement publicly, or to revise any forward-looking statement to reflect events or developments occurring after the date of the statement, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless specifically expressed as such, and should only be viewed as historical data.
About Telos CorporationTelos Corporation (NASDAQ: TLS) empowers and protects the world's most security-conscious organizations with solutions for continuous security assurance of individuals, systems, and information. Telos' offerings include cybersecurity solutions for IT risk management and information security; cloud security solutions to protect cloud-based assets and enable continuous compliance with industry and government security standards; and enterprise security solutions for identity and access management, secure mobility, organizational messaging, and network management and defense. The company serves commercial enterprises, regulated industries and government customers around the world.
Media:media@telos.com
Investors:InvestorRelations@telos.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
35 minutes ago
- Business Wire
Axos Financial Celebrates Twenty-Fifth Anniversary on July 4 th
SAN DIEGO--(BUSINESS WIRE)-- Axos Financial ('Axos') celebrates twenty-five years of successful evolution from a consumer-focused digital bank into a leading full-spectrum financial services firm. Today, Axos serves consumers, small businesses, and commercial and institutional clients nationwide across with a comprehensive range of deposit, lending, and securities services, all delivered with a focus on technological excellence. Over its 25-year history Axos Financial has been widely recognized for its innovation in digital banking and strong financial performance. Axos's founders selected July 4 th as its launch date to symbolize the freedom that a financial services firm focused on digital delivery could provide to clients tethered to the inconvenience and high cost of branch-based financial services delivery. By focusing the client's experience on digital technology and providing the option of reaching industry focused financial services experts, Axos experienced the strong client growth that has allowed it to continue to invest in better technology and expanded services for our clients. 'Our twenty-fifth anniversary is a source of pride for our team given the success we have achieved in serving clients across our diverse businesses. This milestone reflects our ability to adapt, evolve, and execute with discipline,' said Greg Garrabrants, President and CEO of Axos. 'We have proven that a digital first institution can become the primary bank for consumers and businesses by leading with technology. I am proud of what we have achieved and excited about our future. As we look ahead, Axos will continue to drive product and technological innovation to our clients with a relentless focused on driving innovation, deepening customer relationships, and delivering long-term value.' About Axos Financial, Inc. Axos Financial, Inc., with approximately $24.0 billion in consolidated assets as of March 31, 2025, is the holding company for Axos Bank, Axos Clearing LLC and Axos Invest, Inc. Axos Bank provides consumer and business banking products nationwide through its low-cost distribution channels and affinity partners. Axos Clearing LLC (including its business division Axos Advisor Services), with approximately $37.1 billion of assets under custody and/or administration as of March 31, 2025, and Axos Invest, Inc., provide comprehensive securities clearing services to introducing broker-dealers and registered investment advisor correspondents, and digital investment advisory services to retail investors, respectively. Axos Financial, Inc.'s common stock is listed on the NYSE under the symbol 'AX' and is a component of the Russell 2000® Index, the S&P SmallCap 600® Index, the KBW Nasdaq Financial Technology Index, and the Travillian Tech-Forward Bank Index. For more information on Axos Financial, Inc., please visit
Business Wire
2 hours ago
- Business Wire
WELL Health Announces Voting Results for Election of Directors
VANCOUVER, British Columbia--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the ' Company ' or ' WELL '), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that at its annual general meeting held June 30, 2025 (the ' Meeting '), all of the nominees for election as directors of the Company referred to in its notice of meeting and information circular dated May 28, 2025 for the Meeting were elected. A total of 67,105,724 common shares representing 26.52% of the outstanding common shares of the Company were voted by proxy at the Meeting. Voting results for the election of directors at the Meeting were as follows: Resolution Vote Type Total Votes % Voted Kenneth Cawkell For Against Withheld 55,319,811 0 11,776,033 82.45% 0% 17.55% John Kim For Against Withheld 63,350,632 0 3,745,212 94.42% 0% 5.58% Sybil E Jen Lau For Against Withheld 65,493,814 0 1,602,030 97.61% 0% 2.39% Thomas Liston For Against Withheld 58,911,074 0 8,184,770 87.80% 0% 12.20% Tara McCarville For Against Withheld 58,713,637 0 8,382,207 87.51% 0% 12.49% Hamed Shahbazi For Against Withheld 49,082,859 0 18,012,985 73.15% 0% 26.85% Expand The results of other matters considered at the Meeting are reported in the Report of Voting Results as filed on SEDAR+ ( filed on July 4, 2025. WELL HEALTH TECHNOLOGIES CORP. Per: 'Hamed Shahbazi' Hamed Shahbazi Chief Executive Officer, Chairman and Director About WELL Health Technologies Corp. WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 42,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 210 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about the Company, please visit:
Business Upturn
2 hours ago
- Business Upturn
Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market
Lupin Limited has announced the launch of its generic version of Ipratropium Bromide Nasal Solution in the United States. The product will be available in both 0.03% and 0.06% strengths and is a therapeutic equivalent to Boehringer Ingelheim's Atrovent® Nasal Spray. This launch marks Lupin's latest addition to its U.S. generic portfolio. The Ipratropium Bromide Nasal Solution 0.03% is used to provide symptomatic relief of rhinorrhea linked to both allergic and nonallergic perennial rhinitis in adults and children aged six and above. The 0.06% version targets rhinorrhea symptoms associated with the common cold or seasonal allergic rhinitis in adults and children aged five and older. According to IQVIA data for the 12 months ending May 2025, the reference drug Atrovent® recorded estimated annual U.S. sales of approximately USD 63 million. With this launch, Lupin aims to tap into the niche respiratory care segment while expanding access to affordable treatment options for patients in the U.S. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
